Dr. Chandrikha Chandrasekharan, MBBS
Claim this profileUniversity of Iowa/Holden Comprehensive Cancer Center
Studies Neuroendocrine Tumors
Studies Tumors
17 reported clinical trials
40 drugs studied
Area of expertise
1Neuroendocrine Tumors
Stage IV
Stage III
CXCR4 positive
2Tumors
Stage IV
Stage III
PD-L1 positive
Affiliated Hospitals
Clinical Trials Chandrikha Chandrasekharan, MBBS is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Chandrikha Chandrasekharan, MBBS
Clinical Trial Related5 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Chandrikha Chandrasekharan, MBBS has experience with
- Gallium-68 Pentixafor
- Surufatinib
- Tislelizumab
- SY-5609
- Fulvestrant
- Nab-paclitaxel
Breakdown of trials Chandrikha Chandrasekharan, MBBS has run
Neuroendocrine Tumors
Tumors
Pancreatic Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Chandrikha Chandrasekharan, MBBS specialize in?
Chandrikha Chandrasekharan, MBBS focuses on Neuroendocrine Tumors and Tumors. In particular, much of their work with Neuroendocrine Tumors has involved Stage IV patients, or patients who are Stage III.
Is Chandrikha Chandrasekharan, MBBS currently recruiting for clinical trials?
Yes, Chandrikha Chandrasekharan, MBBS is currently recruiting for 8 clinical trials in Iowa City Iowa. If you're interested in participating, you should apply.
Are there any treatments that Chandrikha Chandrasekharan, MBBS has studied deeply?
Yes, Chandrikha Chandrasekharan, MBBS has studied treatments such as Gallium-68 Pentixafor, Surufatinib, Tislelizumab.
What is the best way to schedule an appointment with Chandrikha Chandrasekharan, MBBS?
Apply for one of the trials that Chandrikha Chandrasekharan, MBBS is conducting.
What is the office address of Chandrikha Chandrasekharan, MBBS?
The office of Chandrikha Chandrasekharan, MBBS is located at: University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa 52242 United States. This is the address for their practice at the University of Iowa/Holden Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.